End to End Sequencing Solutions

Whether you are running a population health program, a clinical diagnostic service, or a research study, Biogenix provides the sequencing infrastructure, expertise, and quality standards your work demands.

World-Class Sequencing, Ready to Scale

From sample collection to secure data delivery, Biogenix provides end-to-end sequencing services for clinical laboratories, research institutions, pharmaceutical companies, and national health programs. Our capabilities cover logistics, sample processing, high-throughput sequencing, and automated data analysis, ensuring speed, accuracy, and reliability at every step.

We offer short-read and long-read NGS-based sequencing to support a broad range of applications, including rare disease diagnosis, oncology testing, drug discovery, biomarker research, population-scale genomic programs, and translational research. All sequencing is performed in CAP-accredited, ISO 15189 certified facilities, with data delivered securely and in your preferred format.

Illumina Short-Read

NovaSeq X and NovaSeq 6000 platforms, clinical-grade short-read sequencing, rapid turnaround.

Running on NovaSeq X and NovaSeq 6000 platforms, we primarily deliver whole genome sequencing at clinical grade and population scale, with the flexibility to support targeted sequencing applications where required.

High-Throughput Performance

Process thousands of samples in parallel at clinical and research scale, without compromising quality or turnaround.

Clinical-Grade
Accuracy

Validated workflows and deep coverage ensure high sensitivity and specificity across diagnostics, screening, and genomic reporting.

Fast Turnaround
Time

Optimised protocols and automation deliver results with minimal delay, critical for time-sensitive applications such as newborn screening and oncology.

Scalable for Any Use Case

From whole genome sequencing to targeted applications, our service adapts to your project size, application, and scientific requirements.
Oxford Nanopore Long-read

Long-read sequencing with native methylation profiling, structural variant detection, and real-time capability.

Our Oxford Nanopore long-read sequencing service is designed for researchers and discovery programs requiring resolution that short-read sequencing cannot provide. We support structural variant detection, repeat expansion analysis, complex region phasing, and native methylation profiling, all from a single sequencing run without additional preparation steps.
Long-read sequencing is particularly suited to rare disease research, epigenomic studies, and projects requiring deep biological characterisation at population scale. All data is processed and delivered securely from our state-of-the-art sequencing facility.

Structural Variant Detection

Identify large-scale genomic rearrangements and complex variants that short-read sequencing cannot resolve.

Native Methylation Profiling

Capture epigenomic data directly from sequencing — no additional library preparation required.

Phasing and Haplotyping

Resolve complex genomic regions and determine variant phasing with greater accuracy than short-read approaches.

Real-Time Sequencing

Adaptive sequencing and real-time data analysis for time-sensitive research and clinical applications.